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Abstract:
Objectives: To determine if urinary biomarkers of effect and potential harm 
are elevated in electronic cigarette users compared to non-smokers and if 
elevation correlates with increased concentrations of metals in urine. 
Study Design and Setting: This was a cross-sectional study of biomarkers 
of exposure, effect, and potential harm in urine from non-smokers (n=20), 
electronic cigarette users (n=20), and cigarette smokers (n=13). 
Participant’s screening and urine collection were performed at the Roswell 
Park Comprehensive Cancer Center and biomarker analysis and metal 
analysis was performed at the University of California, Riverside.
Results: Metallothionein was significantly elevated in the electronic 
cigarette group (3761 ± 3932 pg/mg) compared to the non-smokers (1129 ±
1294 pg/mg, p=0.05). 8-OHdG (8-hydroxy-2' -deoxyguanosine) was 
significantly elevated in electronic cigarette users (442.8 ± 300.7 ng/mg) vs 
non-smokers (221.6 ± 157.8 ng/mg, p=0.01). 8-isoprostane showed a 
significant increase in electronic cigarette users (750.8 ± 433 pg/mg) vs non-
smokers (411.2 ± 287.4 pg/mg, p=0.03). Linear regression analysis in the 
electronic cigarette group showed a significant correlation between cotinine 
and total metal concentration; total metal concentration and metallothionein;
cotinine and oxidative DNA damage; and total metal concentration and 
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oxidative DNA damage. Zinc was significantly elevated in the electronic 
cigarette users (584.5 ± 826.6 µg/g) compared to non-smokers (413.6 ± 
233.7 µg/g, p=0.03). Linear regression analysis showed a significant 
correlation between urinary zinc concentration and 8-OHdG in the electronic 
cigarette users.
Conclusions: This study is the first to investigate biomarkers of potential 
harm and effect in electronic cigarette users and to show a linkage to metal 
exposure. The biomarker levels in electronic cigarette users were similar to 
(and not lower than) cigarette smokers. In electronic cigarette users, there 
was a link to elevated total metal exposure and oxidative DNA damage. 
Specifically, our results demonstrate that zinc concentration was correlated 
to oxidative DNA damage. 
What is the key question?
 Is increased electronic cigarette usage associated with elevated metal 
exposure and if such exposure can cause biological harm?
What is the bottom line:
 Biomarkers of exposure (cotinine and metals), effect (metallothionein),
and potential harm (8-isoprostane and 8-OHdG) were elevated in 
electronic cigarette users and were similar to concentrations in 
cigarette smokers; also increased electronic cigarette usage (as 
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measured by cotinine) was correlated with elevated urinary metal 
concentrations, which were correlated with oxidative DNA damage.
Why read on:
 This is one of the first studies to demonstrate a correlation between 
biological harm and electronic cigarette usage, suggesting the metal 
constituents (in particular zinc) in electronic cigarette aerosol can 
cause oxidative DNA damage. Given the recent deaths and pulmonary 
illnesses related to electronic cigarette usage, it is important for 
readers to know about the potential health effects related to electronic 
cigarette usage. 
Strengths and Limitations: 
 This was a cross-sectional study with gender and age-matched 
populations to compare urinary biomarker levels and metal 
concentrations in electronic cigarette users versus cigarette smokers 
and non-smokers.
 This is the first study to demonstrate electronic cigarette users are 
exposed to increased concentrations of potentially harmful levels of 
metals (specifically zinc) that were correlated to elevated oxidative 
DNA damage.
 This study is based on a relatively small population (n=53) and small 
number of biomarkers and should be expanded.
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 In the electronic cigarette and cigarette smoker groups, participants 
were not all using the same products and had different numbers of 
puffs/day. 
Introduction:
Cigarette smoking causes more than 480,000 deaths annually in the 
United States and is the leading cause of preventable death1. Electronic 
cigarettes, which grew in usage over 900% between 2011-2015, do not burn 
tobacco and may be a safer product2. However, there are limited scientific 
data to prove that electronic cigarettes are actually less harmful than 
combustible tobacco products, although they may be harmful in different 
ways. To the contrary, some previous research has demonstrated that 
electronic cigarette aerosols contain potentially harmful chemicals, such as 
acrolein; formaldehyde and benzene3; cytotoxic flavor chemicals, such as 
diacetyl and cinnamaldehyde4,5; metals and ultrafine particles including tin, 
chromium and nickel nanoparticles6,7; and free radicals8. Moreover, some 
electronic cigarette refill fluids and aerosols showed cytotoxicity when tested
in vitro9,10, an effect that has been linked to metals in the refill-fluid6,. An in 
vitro study demonstrated that isolated human alveolar macrophages 
exposed to electronic cigarette vapour induces inflammation and reduces 
phagocytosis leaving the patient more susceptible to pulmonary infections11. 
Moreover, recent case reports have attributed electronic cigarette use to 
several adverse health effects, such as respiratory diseases12, increased risk 
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for cardiovascular disease13, and impaired wound healing after surgery14. 
Several previous studies on electronic cigarettes have evaluated biomarkers 
of exposure in blood, urine, and saliva15,16,17, but none has yet examined and 
quantified biomarkers of effect and potential harm in relation to metals in 
electronic cigarette users.  
This study compares urinary biomarkers of exposure, effect, and 
potential harm in non-smokers, conventional cigarette smokers, and 
electronic cigarette users and accounts for the effect of gender and age on 
biomarker expression. Based on the above studies, we hypothesized that 
there would be an increase in the level of biomarkers of effect and potential 
harm in electronic cigarette users compared to non-smokers and a decrease 
compared to cigarette smokers. The urinary biomarker of effect, 
metallothionein, is a protein that responds to and protects against metal 
toxicity and free radical stress. Urinary biomarkers of potential harm were 
two markers of oxidative stress: (1) 8-isoprostane, a prostaglandin formed by
fatty acid peroxidation, and (2) 8-OHdG, a product of DNA oxidation. Urinary 
biomarkers of exposure were: (1) cotinine, a nicotine metabolite to measure 
smoking or vaping usage, and (2) total concentration of 11 urinary metals, 
which are present in electronic cigarette aerosol6,7,18 and are known to 
associate with metallothionein19,20. Regression analyses were performed to 
identify relationships between biomarkers of exposure (cotinine and metals), 
effect (metallothionein), and potential harm (8-OHdG). To isolate the 
observed oxidative effects to a specific metal, regression analyses were 
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performed between the urinary concentrations of individual metals and 8-
OHdG.    
Materials and Methods
Subjects: The urine samples were from participants who were non-
smokers, cigarette smokers, and electronic cigarette users. Participants were
recruited through local media and flyers posted in various locations around 
the Buffalo, New York area. Potential participants were provided with a brief 
description of the study and had an opportunity to ask questions about the 
study procedures. All potential participants were screened over the phone for
inclusion and exclusion criteria. The exclusion criteria included concurrent 
use of smokeless tobacco, pipes, or cigars; alcohol or illicit drug dependence 
within the past six months or current illicit drug use (including marijuana; 
self-reported); psychiatric illness; and use of Nicotine Replacement Therapy 
(NRT). Information about medication and vitamins/antioxidants/metal usage 
was not collected. All eligible subjects who had been asked to come to the 
clinic for screening were given an informed consent form to read and sign. 
Copies of the signed consent forms were given to the research subject and 
were also stored in a secure location, along with the participant’s research 
chart. Informed written consent was obtained from each participant prior to 
their participation.  Eligible participants were then asked to come to Roswell 
Park Comprehensive Cancer Center for a one-time visit, which lasted 
approximately 1 hour. Spot urine samples were collected during this on-site 
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visit.  The Roswell Park IRB had reviewed all procedures prior to 
implementation (protocol number I 247313).
A total of 53 participants were gender and age matched and selected 
for biomarker analysis. Because age may affect the basal expression level of 
biomarkers, the subjects were separated into those ≤40 years old and ≥41 
years old, with the groups containing 23 and 30 samples, respectively. Out of
these age-separated samples, participants were selected from the non-
smoker, cigarette smoker, and electronic cigarette user groups. Each group 
had approximately equal male and female samples. Using a one-way ANOVA 
and a Tukey’s multiple comparison test, there were no significant differences
in the ages of the younger participants or in the ages of the older 
participants; however, the ages of the younger and older groups were 
significantly different from each other. There were negligible levels of 4-
(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in the non-smokers (2.8 
± 6.3 pg/mg of creatinine) and electronic cigarette users (13.3 ± 18.6 pg/mg
of creatinine) indicative of no tobacco use, in contrast to the cigarette 
smokers (105.7 ± 87.4 pg/mg of creatinine) who had significantly elevated 
NNAL (Supplementary Figure 1). In the non-smokers, no samples had levels 
of cotinine ≥1.0 ng/mg (Supplementary Figure 2), confirming smoking 
abstinence. The demographics of the 53 participants who provided urine 
samples were organized by age, gender, and smoking group (Table 1). 
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Table 1. Demographics of the 53 participants included in this study 
separated by smoking group, age, and gender. All smoking groups 
were gender and age matched.
Age (≤40 
years old)                          
Non-
Smokers      
Cigarette 
Users      
E-Cigarette 
Users      
Sampl
e ID Sex Age Average   Sample ID Sex Age Average   Sample ID Sex Age EC Type Average
33B Male 23     02A Male 28 28 ± 0   04C Male 19 Tank  
07B Male 25     21A Female 24     35C Male 28 Tank  
38B Male 29     17A Female 33 28.5 ± 6.4  17C Male 30 Tank  
21B Male 37               41C Male 34 Tank  
16B Male 40
30.8 ±
7.4             16C Male 40 Tank
30.2 ±
7.8
06B Female 27               06C Female 29 Tank  
09B Female 32               23C Female 32 Tank  
42B Female 33               21C Female 33 Tank  
45B Female 33               28C Female 39 Tank  
44B Female 38
32.6 ±
3.9             27C Female 40 Tank
34.6 ±
4.7
                             
Age (≥41 
years old)                          
Non-
Smokers      
Cigarette 
Users      
E-Cigarette 
Users      
Sampl
e ID Sex Age Average   Sample ID Sex Age Average   Sample ID Sex Age EC Type Average
13B Male 42     08A Male 41     31C Male 45 Tank  
27B Male 46     23A Male 49     37C Male 47 Tank  
26B Male 58     03A Male 65     05C Male 57 Tank  
34B Male 58     28A Male 66     32C Male 60 Tank  
43B Male 66 54 ± 9.8   13A Male 75
59.2 ±
13.8   03C Male 66
Cartomize
r 55 ± 8.9
41B Female 41     14A Female 46     08C Female 44 Tank  
04B Female 46     06A Female 49     13C Female 50 Tank  
28B Female 52     18A Female 57     09C Female 55 Tank  
29B Female 59     33A Female 59     88C Female 55 Tank  
35B Female 61
51.8 ±
8.5   36A Female 69 56 ± 9.1   12C Female 62 Tank
53.2 ±
6.7
Biospecimen Collection:  Spot urine samples were collected from 
participants in a previous study16, and cotinine, NNAL, and creatinine 
concentrations were determined at the Center for Disease Control (CDC) and 
the Roswell Park Comprehensive Cancer Center (RPCCC), respectively. 
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Aliquots of 45 ml of fresh urine samples were transferred to 50-ml Falcon 
tube then centrifuged and immediately frozen at -20°C and stored at the 
RPCCC laboratory. Prior to shipping, samples were thawed, and 1.5 ml 
aliquots were transferred to smaller tubes and shipped frozen to University 
of California, Riverside (UCR) for biomarker analysis. The biomarker study 
was approved under IRB protocol HS-12-023 from UCR.
Selection of Biomarkers: Biomarkers were selected by studying previous 
literature pertaining to urinary biomarkers in smokers21,22,23,24,25. The selection
criteria for our panel of urinary biomarkers was based on our goal to analyze 
metal exposure and oxidative stress (Table 2). To evaluate exposure, 
cotinine and metals were measured in urine samples. Metallothionein, which 
increases when metal exposure is elevated, was used as a biomarker of 
effect.  Conventional cigarettes and electronic cigarettes generate free 
radicals that cause cellular oxidative stress8,26,27. Therefore, oxidative 
damage was evaluated in the three study groups by measuring urinary 8-
isoprostane (a biomarker of lipid peroxidation) and 8-OHdG (a biomarker of 
DNA oxidation). Cigarette smoke and electronic cigarette aerosols contain a 
mixture of metals6,7,28 that could lead to an increased production of 
metallothionein (a metal exposure and ROS scavenging biomarker), which is 
a cysteine-rich protein that functions in metal binding25. All selected 
biomarkers described above have been shown to be specifically associated 
with clinically relevant outcomes and diseases (Table 2). 
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Table 2. Clinical diseases associated with biomarkers measured in 
this study.
Biomarker
Type Associated Diseases References
Exposure    
Selenium
Nausea, vomiting, "garlic breath", nail 
loss, hair loss, cardiovascular disease, 
cardiac arrest, cancer, 
MacFarquhar 2010, See 
2006, Rayman 2012
Zinc
Nausea, vomiting, epigastric pain, 
fatigue, hypertension, hemotoxicity, 
bronchospasms, hepatotoxicity, 
neurotoxicity, cancer
Fosmire 1990, Nriagu 
2007
Effect    
Metallothionein Cancer, cardiomyopathy, oxidative stress, heavy metal toxicity 
Eckschlager 2009, Zhou 
2008, Ruttkay-Nedecky 
2013, Klaassen 2009 
Potential
Harm    
8-OHdG Cancer, cardiovascular disease, neurodegenerative diseases
Kroese 2014, 
Valavanidis 2009, Kim 
2015
8-Isoprostane
Coronary artery disease, 
atherosclerosis, interstitial lung 
disease, non-small cell lung cancer, 
breast cancer
Vassalle 2004, Morrow 
2005, Montuschi 1998, 
Stathopoulos 2014, 
Rossner Jr 2006
Urinary Creatinine Concentrations: Spot urine samples were used since 
biomarkers would not necessarily be stable in samples collected over 24 
hours. Because spot urine samples were used, it was necessary to normalize 
the data to creatinine, which is relatively stable in concentration over time. 
Creatinine concentrations in urine were analyzed at the RPCCC clinical 
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laboratory in Buffalo. There were no significant differences in creatinine 
concentrations in relation to gender or age (Supplementary Figure 3).
Biomarker of Exposure (Cotinine, NNAL and Metal Concentration) 
Analysis: Cotinine and NNAL were measured using previously published29,30 
and fully validated methods. Eleven elements/metals (antimony, cadmium, 
copper, indium, lead, nickel, rubidium, selenium, silver, titanium, and zinc) in
urine samples were measured by inductively coupled mass spectrometry 
(ICP-MS) and used to calculate total urinary metal concentration. The 11 
metals were selected for analysis because they have all been identified in 
electronic cigarette aerosols and are known to associate with 
metallothionein. There was no significant elevation of the total 11 metals in 
the smoking groups, though it is slightly elevated in the electronic cigarette 
group (Supplementary Figure 4). Details of metal analysis are given in the 
Supplementary Information.
Biomarkers of Effect and Potential Harm Analysis Using ELISA: Each 
ELISA kit was quality tested for accuracy and reproducibility using urine 
samples collected in house. Samples were tested in duplicate on three 
different days, and the biomarker concentration was normalized to 
creatinine. A range of sample dilutions was tested to determine the optimal 
dilution for quantification of each biomarker from the kits’ standard curves. 
For all ELISA kits, the coefficient of variation for the three independent 
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experiments was ≤15%, except for metallothionein, which was ≤20%. Any 
urine sample with a biomarker concentration outside the lowest or highest 
limit of quantification was excluded for statistical analysis. In all subsequent 
ELISA analyses, biomarkers were run in duplicate wells for each urine 
sample. 
Following a 1:4 dilution in buffer, urine samples were analyzed to 
determine 8-isoprostane concentration using the Urinary 8-Isoprostane ELISA
kit (Detroit R&D, MI, USA). The concentration of 8-OHdG was determined 
using a DNA Damage (8-OHdG) ELISA Kit (Stress Marq Biosciences, Victoria, 
Canada), following a 1:20 dilution. Urine samples were analyzed for 
metallothionein using a Human Metallothionein ELISA Kit (LifeSpan 
BioSciences, WA, USA), following a 1:20 or 1:40 dilution in sample diluent. 
Statistical Analysis: Two urine samples from the electronic cigarette group
had abnormally high creatinine concentrations (≥3 mg/mL) as detected by a 
statistical outlier test and were removed from further analysis. For each 
urine sample, the biomarker concentration was normalized to its respective 
creatinine concentration. Because the normalized biomarker concentration 
data were not normally distributed, a Box-Cox transformation was performed
after which a 3-way ANOVA was applied in MiniTab 17.0 (MiniTab Inc, PA, 
USA) using gender, age, and smoking group as factors.  Outliers were 
removed if they had a large standardized residual (≥2.0 or ≤-2.0). In all the 
3-way ANOVA models, the 2-way and 3-way interactions were not significant,
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and our final model included age, gender, and smoking group. Post-hoc tests
were used to compare different age groups, gender groups, and smoking 
groups.  When the smoking group was analyzed independently (disregarding 
gender and age), a Dunnett’s post-hoc test was used with the electronic 
cigarette group as the main comparison group, and the comparisons were 
electronic cigarette users vs. non-smokers and electronic cigarette users vs. 
cigarette smokers. All linear correlation analyses were performed using the 
Linear Regression Analysis (R2 and p-value reported) in PRISM 7.0 (GraphPad,
CA, USA). All graphs reported in this manuscript were made in PRISM 7.0.
Patient and Public Involvement: No patients were involved in the 
research planning or design, nor were they involved in any aspect of the 
study besides urine collection. There are no plans to directly disseminate the
results of the research to study participants. The dissemination of results will
be achieved through publication or press release.
Results
Biomarker of Effect
Metallothionein, a biomarker of effect (due to metal and reactive 
oxygen species exposure), in the electronic cigarette group (3761 ± 3932 
pg/mg) was significantly elevated when compared to the non-smokers group 
(1129 ± 1294 pg/mg, p=0.05), and these concentrations were similar to the 
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cigarette smokers group (4096 ± 4320 pg/mg, p=0.95) (Figure 1A). There 
were no differences in age or gender.
Biomarkers of Potential Harm (Oxidative Stress)
A significant elevation in urinary levels of the biomarker of DNA 
oxidation, 8-OHdG, occurred in electronic cigarette users (442.8 ± 300.7 ng/
mg) vs. non-smokers (221.6 ± 157.8 ng/mg, p=0.01) (Figure 1B). There was 
no significant difference between electronic cigarette users (442.8 ± 300.7 
ng/mg) and cigarette smokers (388 ± 235 ng/mg, p=0.75). Age affected 8-
OHdG levels; those ≥41 years old (413.4 ± 256.4 ng/mg) had significantly 
elevated 8-OHdG compared to those ≤40 years (241.2 ± 214.1 ng/mg, 
p=0.02) (Figure 1C). There was no effect on gender.
The lipid peroxidation biomarker, 8-isoprostane, showed a significant 
increase in electronic cigarette users (750.8 ± 433 pg/mg) vs. non-smokers 
(411.2 ± 287.4 pg/mg, p=0.03) (Figure 1D). There was no significant 
difference between electronic cigarette users (750.8 ± 433 pg/mg) and 
cigarette smokers (784.2 ± 546.1 pg/mg, p = 0.96). Moreover, the ≥41-year-
old population (777.6 ± 481.5 pg/mg) was significantly elevated in 8-
isoprostane compared to those ≤40 years (392.6 ± 246.9 pg/mg, p=0.002) 
(Figure 1E). In addition, 8-isoprostane was significantly elevated in females 
(741.8 ± 489.3 pg/mg) vs. males (484.9 ± 345, p=0.04) (Figure 1F). 
Biomarkers of Exposure are Correlated with Oxidative DNA Damage 
in E-Cigarette Users
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Results of linear regression analyses performed on the non-smokers, 
cigarette smokers, and electronic cigarette users are presented in Fig 2 for 
the following correlations: (1) cotinine and total metal concentration (Fig 2A-
C), (2) total metal concentration and metallothionein (Fig 2D-F), (3) cotinine 
and 8-OHdG (Fig 2G-I), and (4) total metal concentration and 8-OHdG (Fig 2J-
L). There were no significant correlations in the non-smokers (Fig 2A, D, G, 
and J).  In the cigarette smokers group, only total metal concentration and 8-
OHdG were significant (Fig 2K, p=0.0003). In the electronic cigarette users 
group, all linear regression analyses were significant: cotinine and total 
metal concentration (Fig 2C, p=0.02), total metal concentration and 
metallothionein (Fig 2F, p=0.04), cotinine and 8-OHdG (Fig 2I, p = 0.02), and
total metal concentration and 8-OHdG (Fig 2L, p = 0.007). 
Selenium and Zinc were Elevated in Electronic Cigarette Users
Two of the 11 metals that were analyzed were significantly elevated in 
the electronic cigarette group. Selenium concentrations (Fig 3A) were 
significantly elevated in the electronic cigarette users (54 ± 20.6 µg/g) 
compared to non-smokers (41.8 ± 14.1 µg/g, p=0.04) and cigarette smokers 
(39.7 ± 17.3 µg/g, p=0.05). Zinc concentrations (Fig 3B) were significantly 
elevated in electronic cigarette users (584.5 ± 826.6 µg/g) compared to non-
smokers (413.6 ± 233.7 µg/g, p=0.03). Zinc in the electronic cigarette users 
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was not significantly elevated when compared to cigarette smokers (470.7 ±
223.6 µg/g, p=0.17).
Zinc was Correlated with Oxidative DNA Damage in Electronic 
Cigarette Users
Regression analysis were performed to compare urinary concentrations
of selenium and zinc to 8-OHdG in the non-smokers, cigarette smokers, or 
electronic cigarette users (Fig 4). There were no significant correlations for 
selenium versus 8-OHdG (Fig 4A-C). In the electronic cigarette users only, 
zinc was significantly correlated to 8-OHdG (p=0.0066) (Fig 4F) In non-
smokers and cigarette smokers, zinc was not correlated to 8-OHdG (Fig 4A, 
B).
Discussion:
Consistent with our hypothesis, our study shows for the first time that 
biomarkers of effect and potential harm were elevated in the urine of the 
electronic cigarette users compared to non-smokers. Moreover, in electronic 
cigarette users, the levels of biomarkers of effect and potential harm were 
positively correlated with biomarkers of exposure to nicotine and metals. 
Importantly, electronic cigarette participants in our study did not report 
using other tobacco products and were not dual users of electronic cigarettes
and conventional cigarettes. Before entering our study, all electronic 
cigarette users who were previous cigarette smokers had abstained from 
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smoking cigarettes for a minimum of six months, and abstinence was 
confirmed by undetectable NNAL (Supplemental Fig 1). Previous literature 
has shown that abstinence from cigarette smoking was concurrently linked 
to a decrease in levels of 8-isoprostane and 8-OHdG, which returned to non-
smokers levels31. Taken together, the above information supports the 
conclusion that the elevation of 8-isoprostane and 8-OHdG in urine was 
associated with electronic cigarette use specifically. Surprisingly, we did not 
find a significant reduction in biomarkers of effect and potential harm 
between electronic cigarette users and cigarette smokers. This observation 
may be explained by the fact that electronic and conventional cigarettes and
their aerosols have anatomical, chemical, and particulate differences, which 
may contribute to physiological harm in separate ways. 
Cigarette smoke and electronic cigarette aerosol contain a mixture of 
metals and free radicals6,7,8,28,32 that could be contributing to the oxidative 
harm in our participants. The metals in electronic cigarette aerosols come 
mainly from the metal components in the atomizer and the e-fluid that is 
heated in the atomizer7,33. Metal concentration in urine was positively 
correlated with cotinine concentration, indicating that metals were elevated 
with increased aerosol exposure. 
Metal increase in urine is further supported by the observed elevation 
in metallothionein, which acts as a heavy metal-binding protein and also 
protects cells from oxidative stress by scavenging ROS25. Metallothionein 
normally binds physiological metals, such as zinc and copper, but can also 
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bind xenobiotic heavy metals such as cadmium, silver and arsenic25,34 that 
are present in cigarette smoke35 and electronic cigarette aerosols7. 
Metallothionein can also associate with at least 20 different 
elements/metals19,20, and 11 of these have been found in cigarette smoke28,36 
or e-cigarette aerosol6,7,18 and were present in the urine of our participants. 
The increase in metallothionein in the electronic cigarette user group was 
positively correlated with increasing metal concentration in their urine and 
was likely a response to metals inhaled by the electronic cigarette users. In 
cigarette smokers, metallothionein was not significantly correlated with 
increasing metal concentration, suggesting other factors such as ROS may 
be contributing to its activation. Also, cigarette smoke can have a different 
composition of metals than e-cigarette aerosol6,7,18,28,36, which were not 
selected for in our 11 metal analysis, and therefore the total metal 
concentration in smokers was not correlated to cotinine concentration.
 Elevation of toxic metals can induce oxidative stress37,38. In the 
electronic cigarette group, there was a significant correlation between total 
metals and oxidative DNA damage. A similar correlation was observed for 
the cigarette smokers. Lipid oxidation was not significantly correlated with 
metal concentration in either the electronic cigarette or cigarette smokers 
groups. There are multiple isoprostanes and isoprostane metabolites formed 
in-vivo during oxidative conditions39, and we measured only 8-isoprostane, 
which may account for the lack of correlation between lipid oxidation and 
metal concentration. In contrast, during DNA oxidation the guanine residue is
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highly oxidized compared to the other nucleic bases, leading to the 
formation of a single DNA oxidation product (8-OHdG), which makes 
correlation to oxidative stress straightforward. 
Both zinc and selenium, which were significantly elevated in the 
electronic cigarette user group, are present in electronic cigarette aerosols, 
usually higher concentrations than most other elements6,7. However, only 
zinc concentration was correlated with oxidative DNA damage in the 
electronic cigarette group. While zinc is required for normal human health, 
its elevation above normal levels has been associated with oxidative stress40.
Our data provide the first evidence that electronic cigarette usage increases 
the risk of zinc exposure, which in turn causes oxidative DNA damage in 
humans. Selenium is also a required trace element that can cause harm 
when elevated41. While its elevation in electronic cigarette users was not 
linked to increased oxidative stress, future work may find that it has other 
adverse health effects. 
Oxidative damage can lead to gradual harm of all organ systems42 and 
if left unchecked can culminate in diseases such as atherosclerosis, coronary
heart disease, pulmonary fibrosis, acute lymphoblastic leukemia, and lung 
cancer43. Of particular concern, increases in both 8-isoprostane and 8-OHdG 
were significantly greater in the older populations, suggesting that 
conventional cigarette users who give up smoking and switched to electronic
cigarettes may be at greater risk for oxidative damage than young people 
who have not smoked previously. In the case of 8-isoprostane, females were 
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more affected than males, suggesting that women should not be encouraged
by physicians to use electronic cigarettes, especially when pregnant. There 
were no significant differences in the elevated concentrations of oxidative 
harm biomarkers between electronic cigarette users and cigarette smokers, 
suggesting their organ systems are exposed to similar levels of oxidative 
damage. 
Conclusions:
Our data show for the first time that electronic cigarette use, which 
correlates with metal intake, leads to an elevation in metallothionein in the 
urine. The usage of e-cigarettes causes an increase in oxidative stress as 
measured by 8-OHdG and 8-isoprostane. E-cigarette users were exposed to 
elevated levels of selenium and zinc. The intake of metals (specifically zinc) 
is further correlated with increased oxidative damage to DNA. These data 
indicate that electronic cigarette use is not harm free and that prolonged use
with elevation of oxidative stress may lead to disease progression. Given 
these observations, physicians should use caution in recommending the use 
of electronic cigarettes to their patients and should be alert to possible 
adverse health outcomes associated with electronic cigarette use. The 
biomarkers used in this study may be valuable in clinical practice when 
evaluating the health of electronic cigarette users. 
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Figure 1. Urinary metallothionein (pg/mg of creatinine), 8-OHdG (ng/
mg of creatinine), 8-isoprostane (pg/mg of creatinine), are 
significantly elevated in e-cigarette users compared to non-
smokers. A. Metallothionein levels among the different smoking groups. B. 
8-OHdG concentration in the different smoking groups. C. 8-OHdG 
concentration in the younger and older populations. D. 8-isoprostane levels 
among the different smoking groups. E. 8-isoprostane levels in the younger 
and older populations. F. 8-isoprostane levels in males and females. Bars are 
the means and standard deviations for each group. * p = < 0.05; ** p = 
<0.01.
Figure 2. Correlation between total metals and cotinine, 
metallothionein and total metals, 8-OHdG and cotinine, and 8-OHdG 
and total metals in urine. A-C. Linear regression analysis comparing total 
metal (µg/g of creatinine) and cotinine concentration (ng/mg of creatinine) in
urine of the non-smokers, cigarette smokers, and e-cigarette user groups. D-
F. Linear regression analysis comparing metallothionein concentration 
(pg/mg of creatinine) and total metal concentration (µg/g of creatinine) in 
urine in the non-smokers, cigarette smokers, and e-cigarette users groups. 
G-I. Linear regression analysis comparing 8-OHdG (ng/mg of creatinine) and 
cotinine (ng/mg of creatinine) concentration in urine of the non-smokers, 
cigarette smokers, and electronic cigarette user groups. J-L. Linear 
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regression analysis comparing 8-OHdG (ng/mg of creatinine) and total metal 
(µg/g of creatinine) concentration in urine of the non-smokers, cigarette 
smokers, and electronic cigarette user groups. N/A = not applicable since 
levels of cotinine in non-smokers was negligable.
Figure 3. Urinary selenium (µg/g of creatinine) and zinc (µg/g of 
creatinine) concentrations are significantly increased in the 
electronic cigarette users. A. Selenium concentrations in the different 
smoking groups. B. Zinc concentrations in the different smoking groups. Bars
are the means and standard deviations for each group. * p = < 0.05.
Figure 4. Zinc concentrations (µg/g of creatinine) are significantly 
correlated to oxidative DNA damage in the electronic cigarette 
users. A-C. Linear regression analysis comparing selenium (µg/g) of 
creatinine and 8-OHdG (ng/mg of creatinine) in urine of the non-smokers, 
cigarette smokers, and e-cigarette user groups. D-F. Linear regression 
analysis comparing zinc (µg/g of creatinine) and 8-OHdG (ng/mg of 
creatinine) in urine in the non-smokers, cigarette smokers, and e-cigarette 
users groups. 
Supplementary Figure 1. NNAL concentration (pg/mg of creatinine) 
among the different smoking groups. Significant elevation of NNAL (a 
biomarker of tobacco exposure) was seen in the cigarette smokers. Bars are 
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the means and standard deviations for each group. * p = < 0.05; **** p = < 
0.0001.
Supplementary Figure 2. Cotinine concentration (ng/mg of 
creatinine) in the different smoking groups. Cotinine concentration is 
elevated in the cigarette smokers and e-cigarette users compared to non-
smokers. There is no difference between the cigarette smokers and e-
cigarette users. Bars are the means and standard deviations for each group. 
** p = < 0.01; **** p = < 0.0001.
Supplementary Figure 3. Urinary creatinine concentration (mg/mL) 
in different genders and age populations.  A. Creatinine concentrations 
in males and females. B. Creatinine concentrations in the younger and older 
population. There were no significant differences between genders or age 
groups. Bars are the means and standard deviations for each group.
Supplementary Figure 4. The total concentration of 11 metals (µg/g 
of creatinine) in each smoking group. There were no significant 
differences in the total metals concentrations in any of the smoking groups. 
Bars are the means and standard deviations for each group.
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